Enfortumab Vedotin and the Role of ADCs in Bladder Cancer


Bladder cancer specialists discuss enfortumab vedotin and the role of antibody-drug conjugates in the treatment landscape.

Related Videos
Eiftu S. Haile, MD, answers a question during a Zoom video interview
A panel of 3 experts on overactive bladder
Related Content
© 2024 MJH Life Sciences

All rights reserved.